Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047203 | 0.80 | — | — | |
| SCHEMBL20429130 | 0.80 | HSD11B1 (0.37) | HSD11B1 | |
| SCHEMBL20803862 | 0.76 | HSD11B1 (0.38) | HSD11B1 | |
| SCHEMBL6579636 | 0.74 | S1PR1 (0.35) | — | |
| SCHEMBL28700224 | 0.74 | — | — | |
| SCHEMBL1555235 | 0.72 | HSD11B1 (0.35) | HSD11B1 | |
| SCHEMBL26050253 | 0.70 | HSD11B1 (0.32) | HSD11B1 | |
| SCHEMBL21618584 | 0.68 | CYP2D6 (0.33) | HSD11B1 | |
| SCHEMBL27615430 | 0.67 | TSHR (0.34) | — | |
| SCHEMBL14359115 | 0.66 | RAB9A (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | claimed |
| EP-3852716-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061556-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-03-26 | — | — | WO | claimed |
| WO-2002043491-A9 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PROD INC (US) | 2003-08-14 | — | — | WO | claimed |
| EP-1250043-A4 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PROD INC (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1250043-A1 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PRODUCTS, INC. (US) | 2002-10-23 | — | — | EP | claimed |
| WO-2002043491-A1 | EXTENDED DURATION INSECT REPELLENT COMPOSITION AND METHOD OF APPLICATION TO THE SKIN | AVON PRODUCTS, INC. (US) | 2002-06-06 | — | — | WO | claimed |
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | disclosed |
| EP-1978803-B1 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2016-04-06 | — | — | EP | disclosed |
| US-8501205-B2 | Insect repellent composition | NO MO FOUNDATION | 2013-08-06 | — | — | US | disclosed |
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2011-07-28 | — | — | US | disclosed |
| US-7846464-B2 | Insect repellent composition | NO MO FOUNDATION | 2010-12-07 | — | — | US | disclosed |
| EP-1978803-A2 | INSECT REPELLENT COMPOSITION | Darling, Samuel T. (CA) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007082306-A2 | INSECT REPELLENT COMPOSITION | DARLING SAMUEL T (CA) | 2007-07-19 | — | — | WO | disclosed |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | NO MO FOUNDATION | 2007-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183017-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | HSD11B1 3868/4885 |
| US-20070166342-A1 | INSECT REPELLENT COMPOSITION | TRPM8, TRPV3, LSM8 | HSD11B1 3868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.